Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 247
interventional 147
Observational 91
Registry 9

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 61
Drug|placebo 28
Other 16
Biological|placebo 11
Biological 10
Behavioral 6
Device 5
Biological|Drug 2
Biological|Drug|placebo 2
Biological|Procedure 2
Drug|Other 1
Genetic|placebo 1
placebo 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
NA 24
China 16
United States 13
France 9
Germany 6
Turkey 5
Norway 4
Brazil 3
Canada 3
Denmark 3
Ireland 3
Korea, Republic of 3
India 2
Japan 2
Russian Federation 2
Switzerland 2
United Kingdom 2
United States|Belgium|Bulgaria|Canada|France|Germany|Italy|Mexico|Netherlands|Peru|Russian Federation|Taiwan|Turkey|United Kingdom 2
United States|Bulgaria|Canada|Czechia|Germany|Hungary|Poland|Russian Federation|Spain|Ukraine 2
United States|Germany|Netherlands|United Kingdom 2
Argentina|Belgium|Colombia|Czech Republic|Finland|France|Germany|Hungary|Korea, Republic of|Netherlands|Russian Federation|Spain|Taiwan|United Kingdom 1
Australia|Austria|China|Czech Republic|Denmark|Finland|France|Germany|Hungary|Ireland|Italy|Netherlands|Poland|Qatar|Saudi Arabia|Spain|Sweden|United Kingdom 1
Austria|Belgium|Denmark|Finland|France|Germany|Greece|Ireland|Italy|Netherlands|Norway|Spain|Sweden|Switzerland|United Kingdom 1
Belarus|Russian Federation 1
Belgium 1
Belgium|Bosnia and Herzegovina|Bulgaria|Czechia|Estonia|Georgia|Latvia|Poland|Spain|Ukraine 1
Belgium|Bulgaria|Czechia|Estonia|Poland|Spain|Ukraine 1
China|Czechia|Korea, Republic of|United Kingdom 1
Cyprus 1
Denmark|Finland|Sweden|United Kingdom 1
Egypt 1
Finland 1
France|Germany|Hungary|Netherlands 1
France|Monaco 1
Hong Kong 1
Iran, Islamic Republic of 1
Israel 1
Mexico|United States|Argentina|Hungary|Poland|Russian Federation|Spain|Ukraine 1
Poland|United States|Belgium|Bulgaria|Czechia|France|Germany|Hungary|Netherlands|Romania|Spain|Taiwan|Turkey|United Kingdom 1
Spain 1
Switzerland|United States|France|Netherlands 1
Taiwan 1
United States|Argentina|Australia|Belgium|Canada|Chile|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Israel|Japan|Korea, Republic of|Mexico|Netherlands|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Lithuania|Netherlands|Poland|Spain|Turkey 1
United States|Australia|Austria|Bulgaria|Canada|Czechia|Denmark|Finland|Germany|Greece|Italy|Netherlands|Norway|Poland|Russian Federation|Slovakia|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Croatia|Czechia|Denmark|Finland|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Portugal|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Colombia|Czechia|Finland|France|Germany|Hungary|Netherlands|Poland|Spain|Sweden|Taiwan 1
United States|Australia|Bulgaria|Canada|China|Czechia|France|Hungary|Israel|Korea, Republic of|Poland|Russian Federation|Turkey|Ukraine 1
United States|Australia|Canada|Germany|Korea, Republic of|Mexico|Poland|Russian Federation|Ukraine 1
United States|Austria|Canada|Czechia|Finland|Germany|Italy|Netherlands|Russian Federation|Singapore|Spain|Switzerland|United Kingdom 1
United States|Belgium 1
United States|Belgium|Bulgaria|China|Czechia|France|Germany|Hungary|Japan|Netherlands|Poland|Spain|Turkey|United Kingdom 1
United States|Belgium|Canada|Finland|France|Germany|Korea, Republic of|Netherlands|Taiwan 1
United States|Belgium|Czechia|Germany|Greece|Mexico|Portugal|Russian Federation|Spain|United Kingdom 1
United States|Canada|Czech Republic|Germany|Hungary|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan 1
United States|Czechia|Germany|Greece|Moldova, Republic of|Netherlands|Poland|Russian Federation 1
United States|Netherlands|Switzerland 1
United States|Poland 1
United States|Spain|Australia|Austria|Bulgaria|Canada|Czechia|Estonia|France|Germany|Hungary|Netherlands|Poland|Romania|Russian Federation|Slovakia|Sweden|United Kingdom 1

Sites per Study

Site_count Study_Count
1 78
2 5
4 1
5 2
6 2
7 2
8 1
9 4
10 3
11 3
14 2
15 1
16 1
19 2
20 1
21 2
22 4
27 1
30 2
31 1
34 2
39 1
40 1
44 1
47 2
49 1
50 1
53 1
56 1
57 1
67 2
68 1
73 1
74 1
80 1
82 1
83 2
85 1
90 1
99 1
101 1
103 1
108 1
196 1
205 1

Phase

Phase Study_Count
Phase 3 49
Phase 4 35
N/A 30
Phase 2 22
Phase 1 7
Early Phase 1 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 33
2 67
3 18
4 8
5 4
6 2
7 1
NA 14

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20 20.0000 17.0000 120 4.000 540 18 10.0000
1st Qu. 32 40.0000 36.5000 120 42.000 540 192 43.0000
Median 44 55.0000 90.0000 120 132.000 540 257 82.0000
Mean 44 115.4138 118.1429 120 159.381 540 320 117.9429
3rd Qu. 56 114.0000 195.0000 120 228.000 540 400 153.0000
Max. 68 611.0000 257.0000 120 617.000 540 1250 566.0000

Trial Group Type

group_type Group_Count
Experimental 163
Active Comparator 64
Placebo Comparator 42
NA 14
Other 11
No Intervention 10
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 106
Single Group Assignment 35
Sequential Assignment 3
NA 2
Crossover Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 118
Supportive Care 6
Prevention 5
Other 4
NA 4
Health Services Research 3
Basic Science 2
Diagnostic 2
Screening 2
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
NA 22
United States 12
France 9
Turkey 6
Sweden 5
Germany 4
Korea, Republic of 3
Russian Federation 3
Taiwan 3
Austria 2
Belgium 2
China 2
Portugal 2
Spain 2
Argentina|Colombia|Korea, Republic of|Malaysia|Mexico|Philippines|Russian Federation|Thailand|Venezuela|Vietnam 1
Australia 1
Belgium|France|Germany|Greece|Italy|Netherlands|Norway|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Brazil 1
Bulgaria|Canada|Czechia|Germany|Greece|Spain|United Kingdom 1
Canada 1
Croatia|Hungary|Israel|Poland|Romania|Slovakia|Ukraine 1
Ireland 1
Italy 1
Japan 1
Norway 1
Saudi Arabia|Kuwait|Qatar|Algeria|Egypt 1
Spain|Belgium|Finland|Germany|Netherlands|Norway|Switzerland|United Kingdom 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 63
2 3
3 2
4 1
6 1
8 2
10 2
14 1
15 3
18 1
20 1
29 1
38 1
43 1
56 1
77 1
80 1
85 1
96 1
163 1
194 1
244 1

Enrollment Metrics

Measure Observational
Min 16.000
1st Qu 99.000
Median 300.000
Mean 8167.626
3rd Qu 1030.500
Max 530000.000

Observation Model

observational_model Study_Count
Cohort 51
Case-Only 12
NA 12
Case-Control 9
Case-Crossover 3
Case Control 2
Family-Based 2

Time Perspective

time_perspective Study_Count
Prospective 61
Cross-Sectional 16
Retrospective 9
NA 4
Other 1

Registries

Studies by Country

Country Study_Count
United States 3
Korea, Republic of 2
NA 2
Australia 1
Canada 1

Sites per Study

Site_count Study_Count
1 8
22 1

Enrollment Metrics

Measure Registries
Min 216.000
1st Qu 1000.000
Median 5000.000
Mean 5369.778
3rd Qu 9587.000
Max 9867.000

Registry Model

observational_model Study_Count
Cohort 8
Other 1

Time Perspective

time_perspective Study_Count
Prospective 9

Follow-up

target_duration Study_Count
10 Years 4
5 Years 2
1 Month 1
3 Years 1
54 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03928743 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03928743 Recruiting UCB Pharma 2021-01-31
NCT03733925 A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis https://ClinicalTrials.gov/show/NCT03733925 Recruiting Johnson & Johnson Private Limited 2021-01-25
NCT03259074 Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) https://ClinicalTrials.gov/show/NCT03259074 Active, not recruiting Novartis 2021-09-02
NCT03211559 Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03211559 Completed Eastern Mediterranean University 2018-12-01
NCT03178487 A Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis ( SELECT Axis 1 ) https://ClinicalTrials.gov/show/NCT03178487 Active, not recruiting AbbVie 2019-01-21
NCT03159767 A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03159767 Completed Western Health and Social Care Trust 2018-05-02
NCT03140657 The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients https://ClinicalTrials.gov/show/NCT03140657 Completed Tabriz University of Medical Sciences 2017-11-07
NCT03117270 A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03117270 Completed Galapagos NV 2018-07-02
NCT03033095 Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers https://ClinicalTrials.gov/show/NCT03033095 Completed University Hospital, Grenoble 2017-07-31
NCT02915354 Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study https://ClinicalTrials.gov/show/NCT02915354 Completed Sun Yat-sen University 2010-09-30
NCT02896127 Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02896127 Completed Novartis 2018-05-14
NCT02893254 Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02893254 Completed Innovent Biologics (Suzhou) Co. Ltd. 2018-01-22
NCT03215277 A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03215277 Completed UCB Pharma 2020-05-25
NCT02763111 Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02763111 Completed Biocad 2017-06-30
NCT02763046 A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02763046 Completed Novartis 2019-09-24
NCT02762812 Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02762812 Completed Biocad 2017-05-31
NCT02758782 NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02758782 Active, not recruiting Charite University, Berlin, Germany 2020-12-31
NCT02750592 Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02750592 Completed Novartis 2017-07-05
NCT02697968 Electroacupuncture for Relieving Pain in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02697968 Completed The University of Hong Kong 2017-09-30
NCT03926195 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03926195 Recruiting Galapagos NV 2021-01-31
NCT02538341 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) https://ClinicalTrials.gov/show/NCT02538341 Active, not recruiting University of Alabama at Birmingham 2019-01-31
NCT02528201 A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02528201 Completed Pfizer 2004-11-30
NCT02509026 Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA https://ClinicalTrials.gov/show/NCT02509026 Completed Pfizer 2019-05-28
NCT02503891 AL-2 MP-1 (Polyimide) Acetabular Liner https://ClinicalTrials.gov/show/NCT02503891 Recruiting M.M.A Tech Ltd. 2018-09-30
NCT02469753 Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes https://ClinicalTrials.gov/show/NCT02469753 Recruiting University Hospital, Bordeaux 2023-06-30
NCT02374502 Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial https://ClinicalTrials.gov/show/NCT02374502 Completed University of Dublin, Trinity College 2015-10-31
NCT02359903 Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02359903 Completed Biocad 2015-11-30
NCT02201043 Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02201043 Completed Shanghai Pharmaceuticals Holding Co., Ltd 2015-02-28
NCT02186873 A Study of Golimumab in Participants With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02186873 Completed Janssen Research & Development, LLC 2015-12-15
NCT02183168 Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02183168 Completed Boehringer Ingelheim 2002-05-31
NCT02159053 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02159053 Completed Novartis 2016-02-23
NCT02154425 A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers https://ClinicalTrials.gov/show/NCT02154425 Completed UCB Pharma 2015-12-31
NCT02098694 Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis https://ClinicalTrials.gov/show/NCT02098694 Completed Norwegian University of Science and Technology 2015-04-30
NCT01351311 Resistance Training Exercise Using the Swiss Ball in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01351311 Completed Federal University of São Paulo 2012-11-30
NCT02047110 BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS) https://ClinicalTrials.gov/show/NCT02047110 Completed AbbVie 2015-03-05
NCT03357471 Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn’s Disease https://ClinicalTrials.gov/show/NCT03357471 Completed UCB Pharma 2018-07-02
NCT03355573 A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03355573 Active, not recruiting UCB Pharma 2022-12-31
NCT02008916 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients https://ClinicalTrials.gov/show/NCT02008916 Completed Novartis 2015-02-23
NCT01988506 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases https://ClinicalTrials.gov/show/NCT01988506 Recruiting Assistance Publique - Hôpitaux de Paris 2020-08-13
NCT01934933 Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01934933 Completed Sun Yat-sen University 2015-09-23
NCT01895764 Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) https://ClinicalTrials.gov/show/NCT01895764 Completed University Hospital, Tours 2015-04-30
NCT01863732 Extension in AS: Sustainability of Benefits, Safety and Tolerability https://ClinicalTrials.gov/show/NCT01863732 Completed Novartis 2018-03-16
NCT01852851 Employment and Arthritis: Making it Work https://ClinicalTrials.gov/show/NCT01852851 Active, not recruiting University of British Columbia 2020-06-30
NCT03350815 Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03350815 Recruiting Novartis 2021-05-28
NCT01786668 Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01786668 Completed Pfizer 2015-03-31
NCT01709656 A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01709656 Completed Sun Yat-sen University 2014-12-31
NCT01690273 Exercise Therapy Program in Ankylosing Spondylitis Patients https://ClinicalTrials.gov/show/NCT01690273 Completed University of Sao Paulo 2013-06-30
NCT01668004 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) https://ClinicalTrials.gov/show/NCT01668004 Completed Merck Sharp & Dohme Corp. 2015-04-30
NCT01649375 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01649375 Completed Novartis 2014-08-04
NCT01610947 Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity https://ClinicalTrials.gov/show/NCT01610947 Completed University Hospital, Montpellier 2018-10-31
NCT01586650 Effects of Aerobic Training in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01586650 Completed Federal University of São Paulo 2012-11-30
NCT01583374 Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01583374 Completed Amgen 2014-02-24
NCT01571206 An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 https://ClinicalTrials.gov/show/NCT01571206 Completed Celltrion 2013-05-31
NCT01517620 Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy https://ClinicalTrials.gov/show/NCT01517620 Completed Sun Yat-sen University 2012-11-30
NCT01463189 Web-based Support to Manage Arthritis Pain https://ClinicalTrials.gov/show/NCT01463189 Completed Inflexxion, Inc. 2012-11-30
NCT01453725 Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) https://ClinicalTrials.gov/show/NCT01453725 Completed Merck Sharp & Dohme Corp. 2014-03-11
NCT01389388 Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease https://ClinicalTrials.gov/show/NCT01389388 Completed Diakonhjemmet Hospital 2013-08-31
NCT01361542 Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population https://ClinicalTrials.gov/show/NCT01361542 Completed All India Institute of Medical Sciences, New Delhi 2011-12-31
NCT01358175 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01358175 Completed Novartis 2014-12-31
NCT01330901 Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01330901 Completed Charite University, Berlin, Germany 2013-04-30
NCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT04436640 Enrolling by invitation UCB Pharma 2023-11-30
NCT04400786 A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS https://ClinicalTrials.gov/show/NCT04400786 Recruiting Shanghai Zhongshan Hospital 2021-12-31
NCT04392596 Study of Bone Mineral Density and Trabecular Bone Score in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04392596 Completed Mansoura University 2020-01-01
NCT04345458 Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04345458 Completed Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 2015-07-13
NCT04301128 The Effect of Mobile Application on Anti-TNF Drug Adherence of Ankylosing Spondylitis Patients: Pilot Study https://ClinicalTrials.gov/show/NCT04301128 Completed Eskisehir Osmangazi University 2019-12-31
NCT04292028 The Effects of Clinical Pilates Training in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04292028 Completed Dokuz Eylul University 2018-06-01
NCT04205851 Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04205851 Completed Kinevant Sciences GmbH 2020-04-07
NCT04156620 Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA https://ClinicalTrials.gov/show/NCT04156620 Recruiting Novartis 2021-08-09
NCT04135508 A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira https://ClinicalTrials.gov/show/NCT04135508 Completed Bio-Thera Solutions 2018-03-22
NCT04089774 Benefit of Adapted Physical Activity for Patients Suffering From Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04089774 Recruiting Hospital St. Joseph, Marseille, France 2022-06-14
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS https://ClinicalTrials.gov/show/NCT04018599 Completed Fresenius Kabi SwissBioSim GmbH 2020-03-17
NCT03932006 A Multicenter,Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03932006 Recruiting Sun Yat-sen University 2019-05-31
NCT03904953 Effects of Pilates Training on Respiratory Muscle Strenght in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03904953 Recruiting Gazi University 2019-06-02
NCT03880968 Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03880968 Completed Second Affiliated Hospital, School of Medicine, Zhejiang University 2014-09-30
NCT03807180 Effects of Tai Chi in Patients With Ankylosing Spondylitis Receiving Anti-tumor Necrosis Factor Alpha Therapy https://ClinicalTrials.gov/show/NCT03807180 Completed Pamukkale University 2019-04-30
NCT03800797 Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03800797 Completed Sun Yat-sen University 2015-12-10
NCT03726645 The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients. https://ClinicalTrials.gov/show/NCT03726645 Enrolling by invitation Hospital District of Helsinki and Uusimaa 2020-04-30
NCT03667625 Stretching in Water and on Land for Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03667625 Completed Dokuz Eylul University 2016-07-31
NCT03639740 Treat-to-target With Secukinumab in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03639740 Recruiting Rigshospitalet, Denmark 2021-02-28
NCT03561649 Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA https://ClinicalTrials.gov/show/NCT03561649 Active, not recruiting University Hospital, Grenoble 2019-12-14
NCT03552276 A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis. https://ClinicalTrials.gov/show/NCT03552276 Active, not recruiting Sun Pharma Global FZE 2023-06-30
NCT03502616 Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) https://ClinicalTrials.gov/show/NCT03502616 Active, not recruiting Pfizer 2019-12-19
NCT03473665 Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT03473665 Completed Columbia University 2019-08-02
NCT03447704 International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03447704 Active, not recruiting Biocad 2019-03-13
NCT03411798 Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS https://ClinicalTrials.gov/show/NCT03411798 Completed Nanfang Hospital of Southern Medical University 2019-07-01
NCT01258738 Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes https://ClinicalTrials.gov/show/NCT01258738 Completed Pfizer 2012-11-30
NCT01248793 Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01248793 Completed Centocor, Inc. 2011-05-31
NCT01220518 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) https://ClinicalTrials.gov/show/NCT01220518 Completed Celltrion 2011-11-30
NCT01212653 Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS) https://ClinicalTrials.gov/show/NCT01212653 Completed Chinese University of Hong Kong 2013-05-31
NCT01208207 A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) https://ClinicalTrials.gov/show/NCT01208207 Completed Merck Sharp & Dohme Corp. 2014-11-12
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing https://ClinicalTrials.gov/show/NCT01174186 Completed Regionshospitalet Silkeborg 2013-06-30
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01114880 Completed Abbott 2010-09-30
NCT01109940 Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01109940 Completed Novartis 2012-12-31
NCT01091675 Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs https://ClinicalTrials.gov/show/NCT01091675 Completed Spanish Foundation of Rheumatology 2013-05-31
NCT01061723 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01061723 Completed Sanofi 2011-06-30
NCT01038011 Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study https://ClinicalTrials.gov/show/NCT01038011 Completed University of Zurich NA
NCT00953979 Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00953979 Completed Sun Yat-sen University 2009-09-30
NCT00944658 Spondylitis Trial of Apremilast for Better Rheumatic Therapy https://ClinicalTrials.gov/show/NCT00944658 Completed Imperial College London 2011-01-31
NCT00936143 Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00936143 Completed Sun Yat-sen University 2009-09-30
NCT00913302 Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00913302 Completed University of Zurich 2009-11-30
NCT00873730 Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain https://ClinicalTrials.gov/show/NCT00873730 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2008-06-30
NCT00844805 Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) https://ClinicalTrials.gov/show/NCT00844805 Completed Merck Sharp & Dohme Corp. 2011-04-30
NCT04125147 Clinical Investigation of MONTAGE in Adults With Spinal Deformity Undergoing Pedicle Subtraction Osteotomy https://ClinicalTrials.gov/show/NCT04125147 Enrolling by invitation Abyrx, Inc. 2021-12-31
NCT00809159 Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00809159 Completed Novartis 2011-05-31
NCT03457285 Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS). https://ClinicalTrials.gov/show/NCT03457285 Recruiting St. James’s Hospital, Ireland 2019-04-17
NCT03092583 Analysis of DNA Methylation in Spondyloarthritis https://ClinicalTrials.gov/show/NCT03092583 Recruiting Centre Hospitalier Universitaire de Besancon 2020-03-31
NCT03074656 The Norwegian Drug Monitoring Study https://ClinicalTrials.gov/show/NCT03074656 Active, not recruiting Diakonhjemmet Hospital 2021-01-01
NCT02963506 A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02963506 Completed UCB Pharma 2017-10-31
NCT02505542 Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo https://ClinicalTrials.gov/show/NCT02505542 Completed UCB Pharma 2019-02-28
NCT02019602 A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta https://ClinicalTrials.gov/show/NCT02019602 Completed UCB Pharma 2016-10-31
NCT00779935 Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient’s Response to Infliximab (Study P04041)(COMPLETED) https://ClinicalTrials.gov/show/NCT00779935 Completed Merck Sharp & Dohme Corp. 2005-10-01
NCT00779012 A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED) https://ClinicalTrials.gov/show/NCT00779012 Completed Merck Sharp & Dohme Corp. 2007-06-01
NCT00778869 Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) https://ClinicalTrials.gov/show/NCT00778869 Completed Merck Sharp & Dohme Corp. 2005-08-31
NCT00764686 A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00764686 Completed University College Dublin 2008-10-31
NCT00762463 Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00762463 Completed Pfizer 2010-06-30
NCT00722514 Evaluation of a Patient Education Program for Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00722514 Completed Rehazentrum Bad Eilsen 2001-02-28
NCT00715091 Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00715091 Completed Charite University, Berlin, Germany 2013-12-31
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00667355 Completed Abbott 2009-05-31
NCT00648141 Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00648141 Completed Pfizer NA
NCT00647517 Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00647517 Completed Chung Shan Medical University 2009-07-31
NCT00643526 A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector https://ClinicalTrials.gov/show/NCT00643526 Completed Centocor, Inc. 2008-01-31
NCT00576706 PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity https://ClinicalTrials.gov/show/NCT00576706 Completed Korea Otsuka Pharmaceutical Co., Ltd. 2010-03-31
NCT00507403 Infliximab and Methotrexate in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00507403 Completed University Hospital, Tours 2009-10-31
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) https://ClinicalTrials.gov/show/NCT00478660 Completed Abbott NA
NCT00458185 Study Evaluating Etanercept in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00458185 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00444340 An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00444340 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00439283 Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00439283 Completed Association de Recherche Clinique en Rhumatologie NA
NCT00434044 Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00434044 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00432432 Combination Methotrexate and Infliximab https://ClinicalTrials.gov/show/NCT00432432 Completed Chinese University of Hong Kong 2006-08-31
NCT00421980 An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00421980 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00421915 Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00421915 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00420238 Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00420238 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-02-28
NCT00418548 Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00418548 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00410046 Extension Study Evaluating Etanercept in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00410046 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2008-10-31
NCT00367211 Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. https://ClinicalTrials.gov/show/NCT00367211 Completed POZEN 2007-09-30
NCT00356356 16.0040 Ankylosing Spondylitis Study https://ClinicalTrials.gov/show/NCT00356356 Completed Amgen 2006-08-31
NCT00265083 A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00265083 Completed Centocor, Inc. 2007-03-31
NCT00247962 Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00247962 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2008-02-29
NCT00207701 A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. https://ClinicalTrials.gov/show/NCT00207701 Completed Centocor, Inc. NA
NCT00202865 Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) https://ClinicalTrials.gov/show/NCT00202865 Completed Merck Sharp & Dohme Corp. 2007-05-01
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00195819 Completed Abbott 2004-10-31
NCT00133315 TNFalfa Blocking Treatment of Spondylarthropathies https://ClinicalTrials.gov/show/NCT00133315 Completed Hvidovre University Hospital NA
NCT00126724 Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects https://ClinicalTrials.gov/show/NCT00126724 Completed Targeted Genetics Corporation 2008-10-31
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00085644 Completed Abbott 2004-12-31
NCT00000433 Blocking Tumor Necrosis Factor in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00000433 Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NA
NCT00000416 Prevention of Arthritis-Related Work Disability https://ClinicalTrials.gov/show/NCT00000416 Completed Boston University Charles River Campus 2001-08-31
NCT00004288 Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00004288 Completed Office of Rare Diseases (ORD) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00085995 Progression of Spinal Fusion in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00085995 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00056719 Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study https://ClinicalTrials.gov/show/NCT00056719 Completed National Institutes of Health Clinical Center (CC) NA
NCT03339089 Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases https://ClinicalTrials.gov/show/NCT03339089 Recruiting AbbVie 2021-06-30
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03006198 Tracking Biologics Along the Silk Road https://ClinicalTrials.gov/show/NCT03006198 Completed Janssen Pharmaceutica N.V., Belgium 2018-12-01
NCT02988674 A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation https://ClinicalTrials.gov/show/NCT02988674 Completed AbbVie 2019-10-16
NCT02925338 National Observational Study On The Use Of Inflectraâ„¢ An Infliximab Biosimilar In Real Life https://ClinicalTrials.gov/show/NCT02925338 Recruiting Pfizer 2020-09-23
NCT02886689 C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France https://ClinicalTrials.gov/show/NCT02886689 Completed Central Hospital, Nancy, France 2010-12-31
NCT02750800 Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) https://ClinicalTrials.gov/show/NCT02750800 Completed AbbVie 2018-04-03
NCT02704845 Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain https://ClinicalTrials.gov/show/NCT02704845 Completed University of Dublin, Trinity College 2016-08-31
NCT02605642 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade https://ClinicalTrials.gov/show/NCT02605642 Completed Pfizer 2018-12-31
NCT02525042 Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach https://ClinicalTrials.gov/show/NCT02525042 Completed Assistance Publique - Hôpitaux de Paris 2014-01-31
NCT02466217 Phenomics in Autoimmune and Inflammatory Diseases https://ClinicalTrials.gov/show/NCT02466217 Recruiting Assistance Publique - Hôpitaux de Paris 2022-07-31
NCT02389075 The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02389075 Enrolling by invitation University of Colorado, Denver 2020-10-31
NCT02333383 Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients https://ClinicalTrials.gov/show/NCT02333383 Completed AbbVie 2017-08-08
NCT02311842 To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS https://ClinicalTrials.gov/show/NCT02311842 Completed Sun Yat-sen University 2013-12-31
NCT02281747 Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries https://ClinicalTrials.gov/show/NCT02281747 Active, not recruiting National Institutes of Health Clinical Center (CC) 2022-05-31
NCT02202850 Defining Remission With Etanercept in AS in Real Life Clinical Practice https://ClinicalTrials.gov/show/NCT02202850 Completed Pfizer 2017-04-26
NCT01313858 A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554) https://ClinicalTrials.gov/show/NCT01313858 Completed Merck Sharp & Dohme Corp. 2015-09-30
NCT01302730 Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study https://ClinicalTrials.gov/show/NCT01302730 Completed Stanford University 2012-03-31
NCT01282372 Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab https://ClinicalTrials.gov/show/NCT01282372 Completed AbbVie 2014-07-31
NCT01277419 German Spondyloarthritis Inception Cohort https://ClinicalTrials.gov/show/NCT01277419 Recruiting Charite University, Berlin, Germany 2030-07-31
NCT01273519 Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab https://ClinicalTrials.gov/show/NCT01273519 Completed AbbVie 2013-01-31
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01856569 Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy https://ClinicalTrials.gov/show/NCT01856569 Completed Pfizer 2015-10-31
NCT01850121 Remicade in the Treatment of Patients With Active Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01850121 Completed Göteborg University 2008-05-31
NCT01845818 Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium https://ClinicalTrials.gov/show/NCT01845818 Completed AbbVie 2017-06-23
NCT01833468 Functional Limitations Due To The Foot Involvement In Spondyloarthritis https://ClinicalTrials.gov/show/NCT01833468 Completed Vakif Gureba Training and Research Hospital 2013-04-30
NCT01797224 OTIS Autoimmune Diseases in Pregnancy Project https://ClinicalTrials.gov/show/NCT01797224 Recruiting University of California, San Diego 2020-01-31
NCT01793285 An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial https://ClinicalTrials.gov/show/NCT01793285 Completed Pfizer 2012-02-29
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01768858 Completed AbbVie 2017-08-13
NCT01754727 Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice https://ClinicalTrials.gov/show/NCT01754727 Completed AbbVie 2015-10-31
NCT01750528 Prevalence and Progression of Periodontitis in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01750528 Completed Seoul National University Hospital 2014-05-31
NCT01685424 Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) https://ClinicalTrials.gov/show/NCT01685424 Completed Merck Sharp & Dohme Corp. 2015-03-01
NCT01577563 Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). https://ClinicalTrials.gov/show/NCT01577563 Completed AstraZeneca 2013-03-31
NCT01567878 Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects https://ClinicalTrials.gov/show/NCT01567878 Completed University of Sao Paulo 2014-12-31
NCT01519375 Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) https://ClinicalTrials.gov/show/NCT01519375 Completed AstraZeneca 2012-05-31
NCT01511926 Descriptive Study in Patients Treated With Vimovoâ„¢, Including Registration of the Physicians’ Prescribing Patterns https://ClinicalTrials.gov/show/NCT01511926 Completed AstraZeneca 2014-03-31
NCT01474876 Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis https://ClinicalTrials.gov/show/NCT01474876 Completed AbbVie 2014-05-31
NCT01417455 Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01417455 Completed Instituto de Medicina Molecular João Lobo Antunes 2015-01-31
NCT01387802 Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01387802 Completed AbbVie 2019-12-16
NCT01357018 Quality of Life in Chronic Arthritis https://ClinicalTrials.gov/show/NCT01357018 Completed Far Eastern Memorial Hospital 2012-12-31
NCT01329380 Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation) https://ClinicalTrials.gov/show/NCT01329380 Completed AbbVie 2017-12-28
NCT01327638 Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082) https://ClinicalTrials.gov/show/NCT01327638 Completed Merck Sharp & Dohme Corp. 2018-09-24
NCT04437394 Evaluation of Functions of Swallowing and Voice in Ankylosing Spondylitis Patients https://ClinicalTrials.gov/show/NCT04437394 Completed Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 2018-10-30
NCT04435860 Muscle Strength Evaluations in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04435860 Recruiting Bezmialem Vakif University 2020-09-15
NCT04411485 Sexual Dysfunction in Partner of Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04411485 Recruiting Antalya Training and Research Hospital 2020-06-30
NCT04320459 Alexithymia in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04320459 Completed Istanbul Medeniyet University 2016-08-01
NCT04212806 French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA) https://ClinicalTrials.gov/show/NCT04212806 Recruiting University Hospital, Grenoble 2020-07-31
NCT04209881 Ovarian Reserve and Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT04209881 Completed Kanuni Sultan Suleyman Training and Research Hospital 2020-05-19
NCT04077164 Chronic Pain, Couples, & Physical Activity https://ClinicalTrials.gov/show/NCT04077164 Recruiting Illinois Institute of Technology 2019-12-31
NCT03941184 Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity https://ClinicalTrials.gov/show/NCT03941184 Recruiting Mayo Clinic 2020-12-31
NCT03937271 Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome https://ClinicalTrials.gov/show/NCT03937271 Active, not recruiting Taipei Veterans General Hospital, Taiwan 2019-05-31
NCT03866135 Bone Mineral Density, Disease Duration, and Activity in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT03866135 Completed Bezmialem Vakif University 2018-12-31
NCT03839862 Faecal Analyses in Spondyloarthritis Therapy https://ClinicalTrials.gov/show/NCT03839862 Recruiting Region Skane 2021-12-31
NCT03761212 Function, Locomotion, Measurement and Inflammation https://ClinicalTrials.gov/show/NCT03761212 Recruiting University Hospital, Grenoble 2021-12-01
NCT03662919 One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study https://ClinicalTrials.gov/show/NCT03662919 Recruiting Biogen 2022-06-30
NCT03557853 Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab https://ClinicalTrials.gov/show/NCT03557853 Active, not recruiting MSD Pharmaceuticals LLC 2019-06-30
NCT03505892 A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST) https://ClinicalTrials.gov/show/NCT03505892 Recruiting AbbVie 2021-06-30
NCT03452735 Fertility Study of Women With Chronic Inflammatory Rheumatism https://ClinicalTrials.gov/show/NCT03452735 Recruiting University Hospital, Toulouse 2019-07-31
NCT01188655 Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT01188655 Completed Pfizer 2010-03-31
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care https://ClinicalTrials.gov/show/NCT01163916 Completed Abbott 2011-11-30
NCT01104987 Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) https://ClinicalTrials.gov/show/NCT01104987 Completed Göteborg University 2016-07-31
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs https://ClinicalTrials.gov/show/NCT01083693 Completed Abbott 2010-06-30
NCT01083121 Surveillance of Humira Injection in Korean Patients https://ClinicalTrials.gov/show/NCT01083121 Completed AbbVie 2012-06-30
NCT01081717 Golimumab Safety and Surveillance Program Using the Ingenix NHI Database https://ClinicalTrials.gov/show/NCT01081717 Completed Janssen Biotech, Inc. 2015-05-31
NCT01079182 Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS) https://ClinicalTrials.gov/show/NCT01079182 Completed AbbVie 2014-05-31
NCT01078558 A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) https://ClinicalTrials.gov/show/NCT01078558 Completed AbbVie 2018-01-11
NCT01078402 EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries https://ClinicalTrials.gov/show/NCT01078402 Completed AbbVie 2011-11-30
NCT01060098 T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade https://ClinicalTrials.gov/show/NCT01060098 Completed Imperial College London 2012-12-31
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment https://ClinicalTrials.gov/show/NCT00902005 Completed Revmatismesykehuset AS 2011-06-30
NCT00900796 Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00900796 Completed Pfizer 2011-05-31
NCT00858819 Clinical Trial of Osteoporosis in Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00858819 Completed Göteborg University 2012-05-31
NCT04426747 Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis https://ClinicalTrials.gov/show/NCT04426747 Recruiting Groupe Hospitalier Pitie-Salpetriere 2019-11-16
NCT01421303 Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. https://ClinicalTrials.gov/show/NCT01421303 Completed Pfizer 2013-12-31
NCT01422694 Natural History and Development of Spondyloarthritis https://ClinicalTrials.gov/show/NCT01422694 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01176682 Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder https://ClinicalTrials.gov/show/NCT01176682 Completed AstraZeneca 2011-08-31
NCT01077843 Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163) https://ClinicalTrials.gov/show/NCT01077843 Completed Merck Sharp & Dohme Corp. 2015-07-01
NCT00760669 An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants https://ClinicalTrials.gov/show/NCT00760669 Completed Janssen Korea, Ltd., Korea 2011-04-30
NCT00751387 Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia https://ClinicalTrials.gov/show/NCT00751387 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2009-09-30
NCT00727298 Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) https://ClinicalTrials.gov/show/NCT00727298 Completed Merck Sharp & Dohme Corp. 2011-08-31
NCT00725543 Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED) https://ClinicalTrials.gov/show/NCT00725543 Completed Merck Sharp & Dohme Corp. 2010-06-30
NCT00724529 Post Marketing Surveillance of Remicade https://ClinicalTrials.gov/show/NCT00724529 Completed Janssen Korea, Ltd., Korea 2011-08-31
NCT00658827 Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis https://ClinicalTrials.gov/show/NCT00658827 Completed Janssen Biotech, Inc. 2016-09-30
NCT00544557 Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00544557 Completed Pfizer 2014-05-31
NCT00383617 Referral Recommendations for Axial Spondyloarthritis https://ClinicalTrials.gov/show/NCT00383617 Completed Charite University, Berlin, Germany 2007-04-30
NCT00227227 Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00227227 Completed Wyeth is now a wholly owned subsidiary of Pfizer NA
NCT00195416 Study Investigating Enbrel Treatment for Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00195416 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2008-08-31
NCT00081562 Genetics of Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT00081562 Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2006-12-31
NCT00056849 Genetic Determinants of Ankylosing Spondylitis Severity https://ClinicalTrials.gov/show/NCT00056849 Completed National Institutes of Health Clinical Center (CC) 2020-01-03
NCT00818168 Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED) https://ClinicalTrials.gov/show/NCT00818168 Completed Merck Sharp & Dohme Corp. 2010-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02840695 Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS) https://ClinicalTrials.gov/show/NCT02840695 Completed Uppsala University 2015-12-31
NCT02557308 An Observational Study to Evaluate Safety and Efficacy of Remsimaâ„¢ in Patients With Ankylosing Spondylitis https://ClinicalTrials.gov/show/NCT02557308 Recruiting Celltrion 2020-06-30
NCT01965132 Korean College of Rheumatology Biologics Registry https://ClinicalTrials.gov/show/NCT01965132 Recruiting Seoul National University Hospital 2024-12-31
NCT01697254 The CARRA Registry https://ClinicalTrials.gov/show/NCT01697254 Completed Duke University 2015-10-31
NCT04095169 Biomarkers in Early-stage Spondyloarthritis https://ClinicalTrials.gov/show/NCT04095169 Active, not recruiting Spine Centre of Southern Denmark 2019-12-31
NCT03840928 AR-Power Patient Powered Research Network https://ClinicalTrials.gov/show/NCT03840928 Recruiting Global Healthy Living Foundation 2025-03-01
NCT03729674 Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs https://ClinicalTrials.gov/show/NCT03729674 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2021-03-30
NCT03470688 Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents https://ClinicalTrials.gov/show/NCT03470688 Recruiting Opal Rheumatology Ltd. 2021-06-01
NCT04402086 Rheumatology Patient Registry and Biorepository https://ClinicalTrials.gov/show/NCT04402086 Recruiting Yale University 2030-06-01